Table 1 CFIR Domain - Process
CFIR Constructsa | Ranking | Reason for Assigned Ranking | Score |
|---|---|---|---|
Planning | F | The innovation was tested in real-time within the organization, assessed and modified, prior to implementation in L&D. There was a role for all stakeholders in the planning process, tracked the implementation process. | 1 |
Engaging | F | Staff members were engaged with the innovation, invited to use the checklist during live cases, participated in debriefings and did not require repeated attempts to engage. This engagement encouraged feedback and enabled the rapid improvement of steps within the checklist. | 1 |
Opinion Leaders | F | Clinical leaders within L&D were engaged with the innovation and were actively involved in each step of implementation, assessment and improvement. | 1 |
Formally Appointed Internal Implementation Leaders | F | A formally appointed quality and safety lead (SKR) supported and enabled implementation of this innovation. Clinical leads and local stakeholder buy-in was present. | 1 |
Champions. | F | The innovation was informally championed by our surgical obstetric divisional lead. | 1 |
External Change Agents | NA | We did not have an outside organization assisting with implementation, this was internally driven and tested. | NA |
Key Stakeholders | F | Key stakeholders, including a designated quality and safety team, were engaged with the innovation and assisted in the development, implementation, assessment and improvement of the innovation. | 1 |
Innovation Participants | NI | The ‘participants’ in this study were considered the patients with confirmed or under investigation for COVID-19. These participants did not impact implementation. | 0 |
Executing | F | The redesigned workflow was implemented rapidly, in a concise manner, according to plan. | 1 |
Reflecting & Evaluating | F | The implementation team consistently assessed the progress of implementation and the quality of the innovation in order to promote continuous quality improvement. | 1 |